Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injections work by mimicking glucagon-like peptide-1 (GLP-1), a hormone that signals fullness to your brain and slows stomach emptying. Clinical trials show patients using semaglutide lost 15-22% of body weight over 68 weeks. PlexusDx compounds prescription-strength semaglutide from licensed 503A pharmacies and delivers it nationwide without insurance, starting at $149 per month.
Understanding How Semaglutide Injection Works
Semaglutide is a GLP-1 receptor agonist that activates appetite-suppressing pathways in your hypothalamus and pancreas. When you inject semaglutide weekly, it increases insulin secretion when blood sugar rises and slows gastric emptying—the rate food moves from your stomach into your small intestine. This dual action creates a prolonged feeling of fullness, which naturally reduces calorie consumption without requiring constant willpower.
Your body's response to semaglutide depends partly on genetic factors affecting your GLP-1 receptors and related peptide pathways. The PlexusDx Precision Peptide Genetic Test identifies how your genes influence semaglutide response by analyzing variants like GLP1R rs6923761, which affects receptor density and sensitivity. Understanding your genetic profile helps your PlexusDx provider optimize your dose and predict the timeline for seeing results.
Step-by-Step Injection Technique for Semaglutide
Semaglutide injections are administered subcutaneously—under the skin—once per week, ideally on the same day each week. PlexusDx ships pre-filled injection pens with clear instructions and a sterile needle kit. Rotate injection sites among your abdomen, upper arm, or thigh to prevent lipodystrophy (fat pad changes). Pinch the skin, insert the needle at a 90-degree angle, press the plunger slowly until it stops, and count to three before removing the needle.
Before injecting, store your semaglutide pen in the refrigerator between 36–46°F (2–8°C) until first use. After starting, you may store it at room temperature for up to 30 days. Always inspect the liquid for particles or discoloration; if the solution appears cloudy or contains crystals, do not use it and contact PlexusDx. Wash your hands, clean the injection site with an alcohol swab, and let it air-dry for at least 10 seconds to reduce infection risk.
Semaglutide Dosing Schedule and Progression
Most semaglutide regimens begin at a low starter dose and increase weekly over four to five weeks to minimize gastrointestinal side effects. A typical progression looks like this: Week 1–4 at 0.25 mg, Week 5–8 at 0.5 mg, Week 9–12 at 1.0 mg, and Week 13 onward at 1.5–2.4 mg depending on your response and tolerance. Your PlexusDx provider monitors your progress at each tier and adjusts timing based on how you tolerate each dose level.
PlexusDx pricing remains flat at $149 per month for compounded semaglutide injections regardless of which dose your provider prescribes—your dose may increase, but your price will not. This transparent pricing model lets you access higher doses without worrying about escalating monthly costs. Some patients reach their target weight at 1.0 mg, while others benefit from advancing to the maximum therapeutic dose; your provider customizes the timeline based on your individual response.
Expected Results and Timeline for Weight Loss
Most patients notice reduced appetite within the first 1–2 weeks of starting semaglutide, though meaningful weight loss typically becomes visible after 4–6 weeks. Clinical data from the STEP trials (Semaglutide Treatment Effect in People with obesity) showed an average loss of 6–8 pounds by Week 12 and 15–22% body weight reduction by Week 68 in patients on maximum doses. Individual results vary based on diet quality, exercise consistency, sleep, and stress management alongside medication.
Genetic factors significantly influence your weight loss trajectory. For example, the FTO rs9939609 variant is associated with increased appetite signaling; if you carry the risk allele, you may see faster initial weight loss with semaglutide because the medication more effectively counters your genetic predisposition. The PlexusDx Precision Peptide Genetic Test identifies these variants and helps your provider predict your likely response pattern, allowing for earlier adjustments if needed.
Managing Side Effects and When to Contact Your Provider
Nausea is the most common side effect, affecting 25–40% of patients during dose escalation, but it typically subsides within 1–2 weeks. Slowing your dose progression, eating smaller meals, staying hydrated, and avoiding fatty or greasy foods significantly reduce nausea severity. Constipation and mild abdominal discomfort may also occur; increasing fiber intake, drinking 80–100 ounces of water daily, and light walking after meals help. These effects are usually temporary and decrease as your body acclimates.
Contact your PlexusDx provider immediately if you experience severe, persistent nausea; signs of pancreatitis (upper abdominal pain radiating to the back); persistent vomiting; severe constipation lasting over three days; or rapid heart rate. If gastrointestinal symptoms become intolerable, your provider may pause your dose progression, reduce your dose, or transition you to PlexusDx's Microdose GLP-1 Protocol ($129/month) or oral semaglutide formulation. Never stop injecting abruptly; coordinate any changes with your provider.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I see weight loss results from semaglutide injections?
Most patients notice reduced appetite within 1–2 weeks and measurable weight loss by Week 4–6. Average losses reach 6–8 pounds by Week 12 and 15–22% body weight by Week 68 in clinical trials. Your individual timeline depends on your starting weight, diet, exercise, genetics, and how quickly your provider progresses your dose.
Can I switch between semaglutide injection and oral semaglutide?
Yes, you can transition between formulations. Injections are absorbed more efficiently and often produce faster results, while oral tablets ($249/month at PlexusDx) offer convenience if injections cause too much nausea. Your PlexusDx provider can guide you through the switch without losing momentum in your weight loss journey.
What does PlexusDx's semaglutide cost, and is it covered by insurance?
PlexusDx compounded semaglutide injections start at $149 per month with no insurance required, no membership fee, and HSA/FSA eligibility. This flat-rate pricing applies regardless of your dose strength—your dose may increase, but your monthly cost stays the same.
Is compounded semaglutide from PlexusDx as safe as brand-name Ozempic?
PlexusDx sources semaglutide from licensed 503A compounding pharmacies under strict federal oversight, ensuring pharmaceutical-grade purity and potency. While compounded medications are not FDA-approved, they follow the same quality standards as brand medications and come with identical active ingredients, though formulation and bioavailability may vary slightly.
How does the PlexusDx Precision Peptide Genetic Test improve my semaglutide results?
The $99 genetic test identifies how your genes influence GLP-1 receptor sensitivity, appetite regulation, and metabolic pathways. Testing variants like GLP1R rs6923761 and FTO rs9939609 helps your provider predict your response pattern, optimize your dose progression, and recommend complementary lifestyle changes for faster, more sustainable weight loss.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Take Ozempic to Lose Weight? A Comprehensive Guide
Are GLP-1 Approved for Weight Loss? Exploring the Latest in Weight Management